Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Ondine Biomedical Inc
OBICurrent price
8.21 GBX
-0.29 GBX (-3.41%)
Last closed
8.5 GBX
Company
www.ondinebio.com
ISIN
CA68234M2058
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
33 467 864 GBX
Yield for 12 month
-6.17 %
1Y
3Y
5Y
10Y
15Y
OBI
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its product platform is Photodisinfection, a light-based antimicrobial technology that provides destruction of pathogens without causing antibiotic resistance. The company's lead product is Steriwave, a nasal photodisinfection solutions that destroys bacteria, viruses, and fungi colonizing the nose which leads to healthcare-associated infections. Its product pipeline also includes the development of topical antiviral therapy for the upper respiratory tract to reduce SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada. Address: 1100 Melville Street, Vancouver, BC, Canada, V6E 4A6
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4 789.37 GBXP/E ratio
–Dividend Yield
–Current Year
+67 164 979 GBX
Last Year
+35 620 366 GBX
Current Quarter
+48 306 843 GBX
Last Quarter
+42 812 719 GBX
Current Year
+39 249 350 GBX
Last Year
+16 023 549 GBX
Current Quarter
+14 452 796 GBX
Last Quarter
+9 722 736 GBX
Key Figures OBI
1 year
3 years
5 years
10 years
EBITDA
-14 605 976 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-159.71 %
PEG Ratio
–
Return On Equity TTM
-685.59 %
Wall Street Target Price
4 789.37 GBX
Revenue TTM
1 655 530 GBX
Book Value
–
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
100.7 %
Dividend Yield
–
Gross Profit TTM
1 270 523 GBX
Earnings per share
-0.03 GBX
Diluted Eps TTM
-0.03 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OBI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OBI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation OBI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
35.7837
Price Sales TTM
20.2158
Enterprise Value EBITDA
-0.4316
Price Book MRQ
3123.0299
Financials OBI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OBI
For 52 weeks
5.07 GBX
11.55 GBX
50 Day MA
7.79 GBX
Shares Short Prior Month
–
200 Day MA
7.69 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart